Long Shen

机构：SciClone Pharmaceuticals (United States) · ORCID：0000-0003-3395-3783

发表论文 101 篇 · 总被引 2188 次 · h-index 27

代表论文

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies (2021 · Blood · 被引 105)
High‐dose sodium‐glucose co‐transporter‐2 inhibitors are superior in type 2 diabetes: A meta‐analysis of randomized clinical trials (2021 · Diabetes Obesity and Metabolism · 被引 23)
High-fat diet-induced intestinal dysbiosis is associated with the exacerbation of Sjogren’s syndrome (2022 · Frontiers in Microbiology · 被引 22)
System Dynamic Model Simulates the Growth Trend of Diabetes Mellitus in Chinese Population: Implications for Future Urban Public Health Governance (2022 · International Journal of Public Health · 被引 18)
Beneficial Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Left Ventricular Function (2021 · The Journal of Clinical Endocrinology & Metabolism · 被引 16)
Evaluating the therapeutic potential of tofacitinib in Sjögren’s disease: a comprehensive clinical and immunological assessment (2025 · Lara D. Veeken · 被引 9)